Show simple item record

dc.contributor.advisorGutiérrez, Ángela María 
dc.contributor.advisorBeltrán Rodríguez, Johnny Adalber 
dc.creatorCorrea Castillo, Diana 
dc.creatorMoreno Benavides, Carlos
dc.descriptionEl dolor es un síntoma muy común en pacientes con Esclerosis Múltiple, pues del 42 al 65% de los enfermos lo presentan, y es calificado como el síntoma más severo entre el 8 y el 32%. Todos los síndromes dolorosos centrales se presentan por lesión o disfunción del sistema nervioso central, causando discapacidad severa y deterioro de la calidad de vida de los pacientes.
dc.description.abstractBackground Pain is a very common symptom in patients with Multiple Sclerosis, because 42 to 65% of patients present it. As the severe symptom, pain in these patients is between 8 to 32%. All central pain syndromes are presented by injury or dysfunction of the central nervous system, causing severe disability and deterioration in the quality of life of patients.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subject.lembEsclerosis múltiple
dc.titleRevisión sistemática de la literatura para el manejo de dolor central en esclerosis múltiple
dc.publisherUniversidad del Rosario
dc.creator.degreeEspecialista en Neurología
dc.publisher.programEspecialización en Neurología
dc.publisher.departmentEscuela de Medicina y Ciencias de la Salud
dc.type.spaTrabajo de grado
dc.rights.accesoBloqueado (Texto referencial)
dc.source.bibliographicCitationNeumann H, Cavalie A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science 1995 Jul 28.269(5223):549-552.
dc.source.bibliographicCitationTsuchida T, Parker KC, Turner V, McFarland HF, Coligan JE, Biddison WE. Autoreactive CD8+ T cell responses to human myelin protein -derived peptides. Proc Natl Acad Sci. USA 1994.91: 10859-10863.
dc.source.bibliographicCitationZilber N, Kahana E. Pitfalls in multiple sclerosis epidemiology. En: Frontiers in Multiple Sclerosis. Clinical research and therapy. Edited O.Abramsky, H Ovadia. (Martin Dunitz 1997):22-28.
dc.source.bibliographicCitationPaty DW, Oger JJF, Kastrukoff Lf et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potencials, oligoclonal banding and CT. Neurology 1988.38:180-185.
dc.source.bibliographicCitationSadovnick Ad, Ebers GC. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993.20 :17-29.
dc.source.bibliographicCitationKuroiwa Y, Igata A, Itahara K et al. Nation wide survey of multiple sclerosis in Japan. Neurology 1975.845-85.
dc.source.bibliographicCitationRosati G, Aiello I, Pirastru MI et al. Epidemiology of multiple sclerosis in northwestern Sardinia : Further evidence for higher frequency in Sardinians compared to other Italians. Neuroepidemiology 1996.15 :10-19.
dc.source.bibliographicCitationArnold DL, Matthews PM, Francis GS et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol. 1992 .31:235-241.
dc.source.bibliographicCitationDemeners C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F, Zalc B, Lubetzki C. Induction of myelination in the central nervous system by electrical activity. Proct Nat Acad Sci. 1996.93:9887-9892.
dc.source.bibliographicCitationBeatty W.W., Paul R.H., Wilbanks S.L., Hames K.A., Blanco C.R. y Goodkin.D.E. Identifying multiple sclerosis patients with mild or global cognitive impairment using the screening examination for cognitive impairment (SEFCI), Neurology 1995.45: 718-723.
dc.rights.ccAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.type.documentAnálisis de caso
dc.creator.degreetypeFull time

Files in this item


This item appears in the following Collection(s)

Show simple item record
Except where otherwise noted, this item's license is described as